BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7351605)

  • 1. Long-term low-dose prostaglandin E1 administration.
    Pitlick P; French JW; Maze A; Kimble KJ; Ariagno RL; Reitz BA
    J Pediatr; 1980 Feb; 96(2):318-20. PubMed ID: 7351605
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of prostaglandin E1 infusion in the management of transposition of the great arteries.
    Benson LN; Olley PM; Patel RG; Coceani F; Rowe RD
    Am J Cardiol; 1979 Oct; 44(4):691-6. PubMed ID: 484498
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged prostaglandin E1 infusion in an infant with cyanotic congenital heart disease.
    Lewis AB; Lurie PR
    Pediatrics; 1978 Apr; 61(4):534-6. PubMed ID: 662477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of prostaglandin E1 in a critically ill infant with transposition of the great arteries.
    Driscoll DJ; Kugler JD; Nihill MR; McNamara DG
    J Pediatr; 1979 Aug; 95(2):259-61. PubMed ID: 448565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].
    van der Sijp JR; Rohmer J
    Tijdschr Kindergeneeskd; 1985 Feb; 53(1):20-5. PubMed ID: 3857721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical management of double aortic arch especially with intracardiac anomalies].
    Higashidate M; Takanashi Y; Honda M; Imai Y; Takao A
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Oct; 33(10):1903-9. PubMed ID: 4086884
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.
    Thanopoulos BD; Andreou A; Frimas C
    Eur J Pediatr; 1987 May; 146(3):279-82. PubMed ID: 3474149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y; Bosi G; Stijns M; Vliers A
    Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac surgery in the infant group.
    O'Donovan TG; Gotsman MS; Schrire V; Barnard CN
    S Afr Med J; 1967 Oct; 41(41):1073-6. PubMed ID: 6061173
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term prostaglandin E1 therapy in congenital heart defects.
    Teixeira OH; Carpenter B; MacMurray SB; Vlad P
    J Am Coll Cardiol; 1984 Mar; 3(3):838-43. PubMed ID: 6537955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current possibilities of heart surgery in congenital heart defects].
    Lacquet LK
    Verh K Acad Geneeskd Belg; 1977; 39(2):105-21. PubMed ID: 930301
    [No Abstract]   [Full Text] [Related]  

  • 16. Definitive correction of congenital heart disease in infancy.
    Crawford FA; Heath BJ; Joransen JA; Watson DG
    J Miss State Med Assoc; 1978 Oct; 19(10):179-82. PubMed ID: 712823
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heart surgery in infants under the age of 2 years].
    Hallén A; Michaëlsson M; Westerholm CJ; Johansson L; Selén MB; Aberg T
    Lakartidningen; 1969 May; 66(21):2210-6. PubMed ID: 5794558
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular surgery in the first year of life.
    Mustard WT; Bedard P; Trusler GA
    J Thorac Cardiovasc Surg; 1970 Jun; 59(6):761-7. PubMed ID: 5446991
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical treatment of congenital heart disease in infancy: why, when, what?
    Subramanian S
    Bol Asoc Med P R; 1983 May; 75(5):205-10. PubMed ID: 6576789
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
    Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y
    Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.